Research analysts at Credit Suisse Group AG initiated coverage on shares of Cigna Corporation (NYSE:CI) in a report issued on Thursday. The brokerage set an “outperform” rating and a $219.00 price target on the health services provider’s stock. Credit Suisse Group AG’s price target would indicate a potential upside of 11.04% from the company’s current price.

CI has been the topic of several other research reports. Zacks Investment Research upgraded shares of Cigna Corporation from a “hold” rating to a “buy” rating and set a $214.00 target price on the stock in a report on Monday, October 9th. Jefferies Group LLC reiterated a “buy” rating and set a $190.00 price objective (down previously from $199.00) on shares of Cigna Corporation in a report on Friday, August 4th. BMO Capital Markets initiated coverage on shares of Cigna Corporation in a report on Monday, October 16th. They set a “market perform” rating and a $210.00 price objective on the stock. BidaskClub lowered shares of Cigna Corporation from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Finally, Deutsche Bank AG upped their price objective on shares of Cigna Corporation from $180.00 to $190.00 and gave the company a “buy” rating in a report on Monday, August 7th. Two equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Cigna Corporation has an average rating of “Buy” and a consensus price target of $194.88.

Cigna Corporation (NYSE:CI) last released its earnings results on Thursday, November 2nd. The health services provider reported $2.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.36 by $0.47. The business had revenue of $10.38 billion for the quarter, compared to analyst estimates of $10.17 billion. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. Cigna Corporation’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.94 earnings per share.

COPYRIGHT VIOLATION NOTICE: This news story was published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another website, it was illegally copied and republished in violation of U.S. & international copyright & trademark laws. The original version of this news story can be read at https://www.americanbankingnews.com/2017/11/02/cigna-corporation-ci-research-coverage-started-at-credit-suisse-group-ag.html.

In other Cigna Corporation news, Chairman Isaiah Harris, Jr. sold 247 shares of the business’s stock in a transaction dated Tuesday, September 12th. The shares were sold at an average price of $185.27, for a total value of $45,761.69. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director William D. Zollars sold 1,232 shares of the business’s stock in a transaction dated Wednesday, September 13th. The shares were sold at an average price of $187.23, for a total transaction of $230,667.36. The disclosure for this sale can be found here. Insiders sold a total of 45,696 shares of company stock valued at $8,070,481 over the last ninety days. 1.30% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Principal Financial Group Inc. boosted its stake in Cigna Corporation by 29.3% in the third quarter. Principal Financial Group Inc. now owns 529,935 shares of the health services provider’s stock valued at $99,066,000 after acquiring an additional 120,056 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its stake in Cigna Corporation by 9.7% in the third quarter. Oregon Public Employees Retirement Fund now owns 73,028 shares of the health services provider’s stock valued at $13,652,000 after acquiring an additional 6,446 shares during the last quarter. United Asset Strategies Inc. purchased a new position in Cigna Corporation in the third quarter valued at about $403,000. USA Financial Portformulas Corp purchased a new position in Cigna Corporation in the third quarter valued at about $3,486,000. Finally, Trillium Asset Management LLC boosted its stake in Cigna Corporation by 1.1% in the third quarter. Trillium Asset Management LLC now owns 162,161 shares of the health services provider’s stock valued at $30,314,000 after acquiring an additional 1,747 shares during the last quarter. Hedge funds and other institutional investors own 88.23% of the company’s stock.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Analyst Recommendations for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.